| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NEPHROS INC | Director | Common Stock | 48,629 | $109,167 | $2.24 | 01 Jan 2025 | Direct |
| RVL Pharmaceuticals plc | Director | Ordinary Shares | 112,557 | $3,512 | $0.0312 | 10 Aug 2023 | Direct |
| NEPHROS INC | Director | Stock Option (right to buy) | 7,050 | 01 Jan 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NEPH | NEPHROS INC | 01 Jan 2025 | 1 | $0 | 4 | Director | 03 Jan 2025, 17:08 |
| NEPH | NEPHROS INC | 14 May 2024 | 1 | $0 | 4 | Director | 16 May 2024, 16:26 |
| NEPH | NEPHROS INC | 13 Dec 2023 | 1 | $0 | 4 | Director | 15 Dec 2023, 16:48 |
| RVLP | RVL Pharmaceuticals plc | 10 Aug 2023 | 1 | -$5,880 | 4 | Director | 14 Aug 2023, 17:35 |
| RVLP | RVL Pharmaceuticals plc | 05 Jul 2023 | 1 | $0 | 4 | Director | 11 Jul 2023, 21:15 |
| NEPH | NEPHROS INC | 05 Jan 2023 | 2 | $0 | 4 | Director | 09 Jan 2023, 15:33 |
| RVLP | RVL Pharmaceuticals plc | 10 Aug 2022 | 1 | $0 | 4 | Director | 12 Aug 2022, 16:07 |
| RVLP | RVL Pharmaceuticals plc | 10 Aug 2022 | 0 | $0 | 3 | Director | 12 Aug 2022, 16:05 |
| NEPH | NEPHROS INC | 14 Dec 2021 | 2 | $0 | 4 | Director | 16 Dec 2021, 20:17 |